Project
Personalisierung der Blasenkrebstherapie anhand von Unterschieden im Mikrobiom der Blase und von Stuhlproben
Ongoing - recruitment active · 2023 until 2024
Engeler Daniel, Langenauer Janine, Lyatoshinsky Pavel, Patzl Sigrid, Zürn Karin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2023
End Date
2024
Financing
Others
Labels
bladder cancer
Brief description/objective
Towards individualization of bladder cancer therapy: the role
of microbiome in BCG responsiveness prediction